Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions
| Autor: | George Crull, Shawn X. Yin, Duohai Pan, Peter Timmins, Daniel McNamara, Balvinder S. Vig |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Materials science
Polymers Pyridones Chemistry Pharmaceutical Analytical chemistry Pharmaceutical Science 02 engineering and technology Calorimetry Methylcellulose 030226 pharmacology & pharmacy law.invention 03 medical and health sciences 0302 clinical medicine Differential scanning calorimetry Drug Stability X-Ray Diffraction law Phase (matter) Spectroscopy Fourier Transform Infrared Drug Discovery Animals Sulfones Fourier transform infrared spectroscopy Crystallization Solubility Calorimetry Differential Scanning Temperature Humidity Isothermal titration calorimetry 021001 nanoscience & nanotechnology Calorimeter Molecular Medicine Powders 0210 nano-technology |
| Zdroj: | Molecular Pharmaceutics. 14:377-385 |
| ISSN: | 1543-8392 1543-8384 |
| DOI: | 10.1021/acs.molpharmaceut.6b00722 |
| Popis: | A generalized screening approach, applying isothermal calorimetry at 37 °C 100% RH, to formulations of spray dried dispersions (SDDs) for two active pharmaceutical ingredients (APIs) (BMS-903452 and BMS-986034) is demonstrated. APIs 452 and 034, with similar chemotypes, were synthesized and promoted during development for oral dosing. Both APIs were formulated as SDDs for animal exposure studies using the polymer hydroxypropylmethlycellulose acetyl succinate M grade (HPMCAS-M). 452 formulated at 30% (wt/wt %) was an extremely robust SDD that was able to withstand 40 °C 75% RH open storage conditions for 6 months with no physical evidence of crystallization or loss of dissolution performance. Though 034 was a chemical analogue with similar physical chemical properties to 452, a physically stable SDD of 034 could not be formulated in HPMCAS-M at any of the drug loads attempted. This study was used to develop experience with specific physical characterization laboratory techniques to evaluate the physical stability of SDDs and to characterize the propensity of SDDs to phase separate and possibly crystallize. The screening strategy adopted was to stress the formulated SDDs with a temperature humidity screen, within the calorimeter, and to apply orthogonal analytical techniques to gain a more informed understanding of why these SDDs formulated with HPMCAS-M demonstrated such different physical stability. Isothermal calorimetry (thermal activity monitor, TAM) was employed as a primary stress screen wherein the SDD formulations were monitored for 3 days at 37 °C 100% RH for signs of phase separation and possible crystallization of API. Powder X-ray diffraction (pXRD), modulated differential scanning calorimetry (mDSC), Fourier transform infrared spectroscopy (FTIR), and solid state nuclear magnetic resonance (ssNMR) were all used to examine formulated SDDs and neat amorphous drug. 452 SDDs formulated at 30% (wt/wt %) or less did not show phase separation behavior upon exposure to 37 °C 100% RH for 3 days. 034 SDD formulations from 10 through 50% (wt/wt %) all demonstrated thermal traces consistent with exothermic phase separation events over 3 days at 37 °C 100% RH in the TAM. However, only the 15, 30, and 50% containing 034 samples showed pXRD patterns consistent with crystalline material in post-TAM samples. Isothermal calorimetry is a useful screening tool to probe robust SDD physical performance and help investigate the level of drug polymer miscibility under a humid stress. Orthogonal analytical techniques such as pXRD, ssNMR, and FTIR were key in this SDD formulation screening to gain physical understanding and confirm or refute whether physical changes occur during the observed thermal events characterized by the calorimetric screening experiments. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|